Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker EDIT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 21,164 | $2.42 | $51.1K Sale | Form 4 ↗ |
| Nov 11, 2026 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 7,814 | $2.42 | $18.9K Sale | Form 4 ↗ |
| Sep 3, 2026 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 453 | $3.04 | $1,377 Sale | Form 4 ↗ |
| Sep 3, 2026 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 709 | $3.04 | $2,155 Sale | Form 4 ↗ |
| Sep 3, 2026 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 5,124 | $3.04 | $15.6K Sale | Form 4 ↗ |
| Aug 3, 2026 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 678 | $2.58 | $1,749 Sale | Form 4 ↗ |
| Jul 28, 2026 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 4,928 | $2.67 | $13.2K Sale | Form 4 ↗ |
| Jun 3, 2026 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 464 | $2.70 | $1,253 Sale | Form 4 ↗ |
| Jun 3, 2026 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 15,380 | $2.70 | $41.5K Sale | Form 4 ↗ |
| Jun 3, 2026 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 731 | $2.70 | $1,974 Sale | Form 4 ↗ |
| Mar 3, 2026 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 5,394 | $2.02 | $10.9K Sale | Form 4 ↗ |
| Mar 3, 2026 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 474 | $2.02 | $957 Sale | Form 4 ↗ |
| Mar 3, 2026 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 749 | $2.02 | $1,513 Sale | Form 4 ↗ |
| Dec 3, 2025 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 713 | $2.15 | $1,533 Sale | Form 4 ↗ |
| Dec 3, 2025 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 5,603 | $2.15 | $12.0K Sale | Form 4 ↗ |
| Dec 3, 2025 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 461 | $2.15 | $991 Sale | Form 4 ↗ |
| Sep 3, 2025 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 710 | $2.60 | $1,846 Sale | Form 4 ↗ |
| Sep 3, 2025 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 458 | $2.60 | $1,191 Sale | Form 4 ↗ |
| Sep 3, 2025 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 5,592 | $2.60 | $14.5K Sale | Form 4 ↗ |
| Aug 7, 2025 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 679 | $2.58 | $1,752 Sale | Form 4 ↗ |
| Jul 31, 2025 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 5,121 | $2.49 | $12.8K Sale | Form 4 ↗ |
| Jun 3, 2025 | Amy Parison SVP, Chief Financial Officer | EDIT Editas Medicine, Inc. | Sale | 446 | $1.72 | $767 Sale | Form 4 ↗ |
| Jun 3, 2025 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 726 | $1.72 | $1,249 Sale | Form 4 ↗ |
| Jun 3, 2025 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 15,192 | $1.72 | $26.1K Sale | Form 4 ↗ |
| Mar 4, 2025 | Erick Lucera EVP, CHIEF FINANCIAL OFFICER | EDIT Editas Medicine, Inc. | Sale | 4,109 | $1.71 | $7,026 Sale | Form 4 ↗ |
| Mar 4, 2025 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 16,632 | $1.71 | $28.4K Sale | Form 4 ↗ |
| Mar 4, 2025 | Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER | EDIT Editas Medicine, Inc. | Sale | 2,891 | $1.71 | $4,944 Sale | Form 4 ↗ |
| Dec 3, 2024 | Gilmore Neil O'Neill CEO, Director | EDIT Editas Medicine, Inc. | Sale | 1,618 | $2.08 | $3,365 Sale | Form 4 ↗ |
| Dec 3, 2024 | Baisong Mei EVP, CHIEF MEDICAL OFFICER | EDIT Editas Medicine, Inc. | Sale | 541 | $2.08 | $1,125 Sale | Form 4 ↗ |
29 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:00 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances